Kazuhiko Yamamoto

Kazuhiko Yamamoto's AcademicInfluence.com Rankings

Kazuhiko Yamamoto

Law

#3179

World Rank

#4001

Historical Rank

Jurisprudence

#100

World Rank

#187

Historical Rank

International Law

#1296

World Rank

#1551

Historical Rank

law Degrees

Download Badge

Why Is Kazuhiko Yamamoto Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Kazuhiko Yamamoto's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Identification of melatonin in plants and its effects on plasma melatonin levels and binding to melatonin receptors in vertebrates. (1995) (710)
Induction of inflammatory arthropathy resembling rheumatoid arthritis in mice transgenic for HTLV-I (1991) (355)
Distribution and regulation of plasminogen activator inhibitor-1 in murine adipose tissue in vivo. Induction by tumor necrosis factor-alpha and lipopolysaccharide. (1996) (351)
Long-term safety and efficacy of tocilizumab, an anti-IL-6 receptor monoclonal antibody, in monotherapy, in patients with rheumatoid arthritis (the STREAM study): evidence of safety and efficacy in a 5-year extension study (2008) (319)
Apoptosis and functional Fas antigen in rheumatoid arthritis synoviocytes. (1995) (245)
Suppressed severity of collagen-induced arthritis by in vivo transfection of nuclear factor kappaB decoy oligodeoxynucleotides as a gene therapy. (1999) (231)
Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat and rabbit hindlimb ischemia models: preclinical study for treatment of peripheral arterial disease (2001) (226)
Tissue distribution and regulation of murine von Willebrand factor gene expression in vivo. (1998) (220)
Fibrin deposition in tissues from endotoxin-treated mice correlates with decreases in the expression of urokinase-type but not tissue-type plasminogen activator. (1996) (215)
Localization of peptidylarginine deiminase 4 (PADI4) and citrullinated protein in synovial tissue of rheumatoid arthritis. (2005) (206)
High diagnostic performance of ELISA detection of antibodies to citrullinated antigens in rheumatoid arthritis (2003) (172)
Phosphorylation of p38 mitogen-activated protein kinase downstream of bax-caspase-3 pathway leads to cell death induced by high D-glucose in human endothelial cells. (2001) (168)
Accumulation of multiple T cell clonotypes in the synovial lesions of patients with rheumatoid arthritis revealed by a novel clonality analysis. (1992) (167)
PGE2‐EP2 signalling in endothelium is activated by haemodynamic stress and induces cerebral aneurysm through an amplifying loop via NF‐κB (2011) (145)
Potential role of hepatocyte growth factor, a novel angiogenic growth factor, in peripheral arterial disease: downregulation of HGF in response to hypoxia in vascular cells. (1999) (134)
Detection of human T cell lymphotropic virus type I proviral DNA and its gene expression in synovial cells in chronic inflammatory arthropathy. (1991) (126)
Citrullinated fibrinogen detected as a soluble citrullinated autoantigen in rheumatoid arthritis synovial fluids (2006) (125)
Inhibition of intimal hyperplasia after balloon injury in rat carotid artery model using cis-element ‘decoy’ of nuclear factor-kB binding site as a novel molecular strategy (2001) (123)
Cyclic AMP inhibited proliferation of human aortic vascular smooth muscle cells, accompanied by induction of p53 and p21. (2000) (115)
Citrullination of fibronectin in rheumatoid arthritis synovial tissue. (2005) (113)
In vivo administration of a nuclear transcription factor-kappaB decoy suppresses experimental crescentic glomerulonephritis. (2000) (113)
Arthritis in patients infected with human T lymphotropic virus type I. Clinical and immunopathologic features. (1991) (109)
Overexpression of human lipoprotein lipase in transgenic mice. Resistance to diet-induced hypertriglyceridemia and hypercholesterolemia. (1993) (108)
Plasma lipoprotein metabolism in transgenic mice overexpressing apolipoprotein E. Accelerated clearance of lipoproteins containing apolipoprotein B. (1992) (100)
Potential role of hepatocyte growth factor in the maintenance of renal structure: anti-apoptotic action of HGF on epithelial cells. (1998) (94)
Hypoxia-induced endothelial apoptosis through nuclear factor-kappaB (NF-kappaB)-mediated bcl-2 suppression: in vivo evidence of the importance of NF-kappaB in endothelial cell regulation. (2000) (94)
Fine epitope mapping of the human SS-B/La protein. Identification of a distinct autoepitope homologous to a viral gag polyprotein. (1990) (91)
Association between a single-nucleotide polymorphism in the promoter of the human interleukin-3 gene and rheumatoid arthritis in Japanese patients, and maximum-likelihood estimation of combinatorial effect that two genetic loci have on susceptibility to the disease. (2001) (87)
P2X(4) receptors mediate ATP-induced calcium influx in human vascular endothelial cells. (2000) (82)
The assignment of chain specificities for anti-Ia monoclonal antibodies using L cell transfectants. (1986) (79)
High frequencies of identical T cell clonotypes in synovial tissues of rheumatoid arthritis patients suggest the occurrence of common antigen-driven immune responses. (1996) (74)
Possible involvement of Epstein-Barr virus in polyclonal B cell activation in Sjögren's syndrome. (1988) (74)
Autoantibodies to T cell costimulatory molecules in systemic autoimmune diseases. (1999) (72)
Overgrowth of human synovial cells driven by the human T cell leukemia virus type I tax gene. (1993) (70)
Stable clonal expansion of T cells induced by bone marrow transplantation. (1996) (70)
Actions of hepatocyte growth factor as a local modulator in the kidney: potential role in pathogenesis of renal disease. (1998) (68)
The inhibition of antithrombin by peptidylarginine deiminase 4 may contribute to pathogenesis of rheumatoid arthritis. (2005) (62)
Inhibition of the p53 tumor suppressor gene results in growth of human aortic vascular smooth muscle cells. Potential role of p53 in regulation of vascular smooth muscle cell growth. (1999) (59)
Safety of tacrolimus, an immunosuppressive agent, in the treatment of rheumatoid arthritis in elderly patients. (2006) (58)
Detection and epitope analysis of autoantigen-reactive T cells to the U1-small nuclear ribonucleoprotein A protein in autoimmune disease patients. (1993) (58)
Peptidylarginine deiminase 4 (PADI4) identified as a conformation‐dependent autoantigen in rheumatoid arthritis (2005) (57)
Significantly increased maternal and fetal IgG autoantibody levels to 52 kD Ro (SS-A) and La(SS-B) in complete congenital heart block. (1995) (55)
Dynamic changes of accumulated T cell clonotypes during antigenic stimulation in vivo and in vitro. (1994) (55)
Induction of LDL receptor-related protein during the differentiation of monocyte-macrophages. Possible involvement in the atherosclerotic process. (1994) (55)
Secretion-recapture process of apolipoprotein E in hepatic uptake of chylomicron remnants in transgenic mice. (1994) (54)
Accumulation of multiple T cell clonotypes in lungs of healthy individuals and patients with pulmonary sarcoidosis. (1994) (53)
Isolation and characterization of a complementary DNA expressing human U1 small nuclear ribonucleoprotein C polypeptide. (1988) (53)
Characterisation of fibroblast-like cells in pannus lesions of patients with rheumatoid arthritis sharing properties of fibroblasts and chondrocytes (1997) (53)
Extrahepatic expression and regulation of protein C in the mouse. (1998) (51)
Accumulation of distinct T cell clonotypes in human solid tumors. (1995) (51)
Constitutive production of interleukin 6/B cell stimulatory factor-2 from inflammatory synovium. (1989) (50)
A single nucleotide polymorphism in the IRF5 promoter region is associated with susceptibility to rheumatoid arthritis in the Japanese population (2008) (50)
Erythropoietin and IL-3 induce tyrosine phosphorylation of CrkL and its association with Shc, SHP-2, and Cbl in hematopoietic cells. (1997) (48)
Inhibition of growth of human vascular smooth muscle cells by overexpression of p21 gene through induction of apoptosis. (1998) (48)
Novel mechanisms of selective apoptosis in synovial T cells of patients with rheumatoid arthritis. (1996) (47)
DNA mimics a self-protein that may be a target for some anti-DNA antibodies in systemic lupus erythematosus. (1995) (47)
Activation of transcription factor NF-kappa B in human synovial cells in response to tumor necrosis factor alpha. (1996) (46)
Overexpression of human lipoprotein lipase in transgenic mice. Resistance to diet-induced hypertriglyceridemia and hypercholesterolemia. (1993) (44)
Sp1-mediated downregulation of P2X4 receptor gene transcription in endothelial cells exposed to shear stress. (2001) (43)
Spontaneous production of Epstein-Barr virus by B lymphoblastoid cell lines obtained from patients with Sjögren's syndrome. Possible involvement of a novel strain of Epstein-Barr virus in disease pathogenesis. (1993) (43)
Clonal expansion of T cells that are specific for autologous ovarian tumor among tumor-infiltrating T cells in humans. (1999) (42)
cDNA cloning, expression and chromosome mapping of the human STAT4 gene: both STAT4 and STAT1 genes are mapped to 2q32.2-->q32.3. (1997) (41)
Anti-52 kDa Ro(SSA) autoantibodies in different autoimmune diseases preferentially recognize epitopes on the central region of the antigen. (1996) (41)
Association study of TRAF1-C5 polymorphisms with susceptibility to rheumatoid arthritis and systemic lupus erythematosus in Japanese (2009) (40)
Autoepitopes of the 52-kd SS-A/Ro molecule. (1995) (39)
Identification of Ro(SSA) 52 kDa reactive T cells in labial salivary glands from patients with Sjögren's syndrome. (1995) (39)
Shear Stress Induces Hepatocyte PAI-1 Gene Expression Through Cooperative Sp1/Ets-1 Activation of Transcription (2006) (38)
Induction of Fas-dependent apoptosis in synovial infiltrating cells in rheumatoid arthritis. (1996) (38)
One gene encodes two distinct Ia-associated invariant chains. (1985) (37)
Identification of 142 single nucleotide polymorphisms in 41 candidate genes for rheumatoid arthritis in the Japanese population (2000) (37)
Establishment and application of a novel T cell clonality analysis using single-strand conformation polymorphism of T cell receptor messenger signals. (1996) (36)
Idiotypic vaccination with a murine anti-dsDNA antibody: phase I study in patients with nonactive systemic lupus erythematosus with nephritis. (1999) (35)
Immunological and immunohistochemical analysis of rheumatoid nodules. (1989) (34)
Novel therapeutic strategy for atherosclerosis: ribozyme oligonucleotides against apolipoprotein(a) selectively inhibit apolipoprotein(a) but not plasminogen gene expression. (1998) (33)
Overexpression of human lipoprotein lipase protects diabetic transgenic mice from diabetic hypertriglyceridemia and hypercholesterolemia. (1995) (31)
T cell clonality in synovial fluid of a patient with rheumatoid arthritis: persistent but fluctuant oligoclonal T cell expansions. (1997) (31)
Accumulation of human T lymphotropic virus (HTLV)-I-specific T cell clones in HTLV-I-associated myelopathy/tropical spastic paraparesis patients. (1997) (31)
Correlation of clonal T cell expansion with disease activity in systemic lupus erythematosus. (1997) (30)
Direct suppression of human synovial cell proliferation in vitro by salazosulfapyridine and bucillamine. (1996) (30)
Binding sequence of STAT4: STAT4 complex recognizes the IFN-gamma activation site (GAS)-like sequence (T/A)TTCC(C/G)GGAA(T/A). (1997) (29)
The kidneys of mice with autoimmune disease acquire a hypofibrinolytic/procoagulant state that correlates with the development of glomerulonephritis and tissue microthrombosis. (1997) (28)
CUL1, a component of E3 ubiquitin ligase, alters lymphocyte signal transduction with possible effect on rheumatoid arthritis (2005) (28)
Analysis of accumulated T cell clonotypes in patients with systemic lupus erythematosus. (2000) (27)
Overexpression of human lipoprotein lipase increases hormone-sensitive lipase activity in adipose tissue of mice. (1995) (27)
Serum deprivation-induced apoptosis accompanied by up-regulation of p53 and bax in human aortic vascular smooth muscle cells. (1997) (27)
Therapeutic selective adsorption of anti-DNA antibody using dextran sulfate cellulose column (Selesorb) for the treatment of systemic lupus erythematosus. (1998) (26)
Frequent immune response to a melanocyte specific protein KU-MEL-1 in patients with Vogt-Koyanagi-Harada disease (2006) (25)
Frequent clonal expansion of peripheral T cells in patients with autoimmune diseases: A novel detecting system possibly applicable to laboratory examination (1998) (25)
Clonotypic analysis of T cells in patients with autoimmune and viral hepatitis (1997) (25)
Identification of a universal B cell epitope on DNA topoisomerase I, an autoantigen associated with scleroderma. (1993) (25)
In vivo evidence of the importance of cardiac angiotensin-converting enzyme in the pathogenesis of cardiac hypertrophy. (2000) (25)
Changes of endothelin in streptozotocin-induced diabetic rats: effects of an angiotensin converting enzyme inhibitor, enalapril maleate. (2002) (23)
Serologic characteristics in primary biliary cirrhosis associated with sicca syndrome. (1994) (23)
Frequency of clonally expanded T cells evaluated by PCR from a single cell. (1999) (23)
Effect of eicosapentaenoic acid ethyl ester on hypothyroid function. (2001) (23)
A Human Monoclonal Antibody to High‐Frequency Red Cell Antigen Jra (1994) (22)
T cell receptor clonotypes in skin lesions from patients with systemic lupus erythematosus. (1998) (22)
Detection of autoantibodies to killer immunoglobulin-like receptors using recombinant fusion proteins for two killer immunoglobulin-like receptors in patients with systemic autoimmune diseases. (2001) (22)
Tissue-type plasminogen activator, type 1 plasminogen activator inhibitor and their complex in plasma with disseminated intravascular coagulation. (1992) (22)
Assignment of IL12RB1 and IL12RB2, interleukin-12 receptor beta 1 and beta 2 chains, to human chromosome 19 band p13.1 and chromosome 1 band p31.2, respectively, by in situ hybridization. (1997) (21)
Characterisation of T cell clonotypes that accumulated in multiple joints of patients with rheumatoid arthritis (1999) (20)
Platelet-derived growth factor BB-dimer suppresses the expression of macrophage colony-stimulating factor in human vascular smooth muscle cells. (1992) (20)
In vitro effect of Triton WR-1339 on canine plasma high density lipoproteins. (1984) (20)
The effects of CD40‐ and interleukin (IL‐4)‐activated CD23+ cells on the production of IL‐10 by mononuclear cells in Graves’ disease: the role of CD8+ cells (2002) (20)
Establishment and characterization of synovial cell clones with integrated human T-cell leukemia virus type-I. (1994) (19)
In Vitro and In Vivo Interactions of Triton 1339 with Plasma Lipoproteins of Normolipidemic Rhesus Monkeys: Preferential Effects on High Density Lipoproteins (1984) (17)
Possible role of VEGF in the progression of kidney disease in streptozotocin (STZ)-induced diabetic rats: effects of an ACE inhibitor and an angiotensin II receptor antagonist. (2004) (17)
A multicenter study of leukocytapheresis in rheumatoid arthritis. (2007) (17)
Contribution of a vascular modulator, hepatocyte growth factor (HGF), to the pathogenesis of cardiovascular disease. (1998) (17)
Obesity enhances the induction of plasminogen activator inhibitor‐1 by restraint stress: a possible mechanism of stress‐induced renal fibrin deposition in obese mice (2005) (16)
Physical interaction between interleukin-12 receptor beta 2 subunit and Jak2 tyrosine kinase: Jak2 associates with cytoplasmic membrane-proximal region of interleukin-12 receptor beta 2 via amino-terminus. (1999) (16)
Overexpression of human lipoprotein lipase enhances uptake of lipoproteins containing apolipoprotein B-100 in transfected cells. (1994) (16)
The therapeutic effect of lipo PGE1 on diabetic neuropathy-changes in endothelin and various angiopathic factors. (2001) (16)
Possible involvement of Epstein-Barr virus (EBV) in polyclonal B-cell activation in Sjögren's syndrome. (1989) (16)
Clonotypic analysis of T cells infiltrating the skin of patients with atopic dermatitis: evidence for antigen-driven accumulation of T cells. (1996) (15)
Establishment of a novel B cell clonality analysis using single-strand conformation polymorphism of immunoglobulin light chain messenger signals. (1998) (14)
Paired cloning of the T cell receptor α and β genes from a single T cell without the establishment of a T cell clone (2001) (13)
Clonal analysis of T cell infiltrates in synovial tissue of patients with rheumatoid arthritis. (1990) (12)
The ability of disease modifying antirheumatic drugs to induce and maintain improvement in patients with rheumatoid arthritis. epidemiology of DMARDs treatment in Japan. (2005) (12)
Detection of autoantibodies to Ro(SS-A), La(SS-B) and U1RNP in different congenital heart rhythm disorders using immunoblot and enzyme immunoassay. (1994) (12)
Expression of transforming growth factor-beta and tumor necrosis factor-alpha in the plasma and tissues of mice with lupus nephritis. (2000) (12)
Induction of IL-2 receptor expression and proliferation of T cell clones by a novel cytokine(s). (1992) (11)
Clonal prevalence of T cells infiltrating into the pancreas of prediabetic non-obese diabetic mice. (1996) (11)
Characterization of T cell receptor beta chains of accumulating T cells in skin allografts in mice. (1996) (11)
Comparison of the J beta gene usage among different T cell receptor V beta families in spleens of C57BL/6 mice. (1995) (10)
A stable prostacyclin analogue reduces high serum TNF-alpha levels in diabetic patients. (2004) (10)
Differential requirement for humoral factors for IL-2R expression of murine T cell subsets, Th1, Th2, and CD8Th clones. (1993) (10)
Oligoclonal proliferation of human T-cell leukemia virus type I infected lymphocytes in lesions of virus-induced arthropathy. (1995) (10)
Plasma lipoprotein changes attending the intravenous administration of Triton WR-1339 in normolipidemic dogs: preferential effect on high density lipoproteins. (1985) (8)
Relationship between autoepitope and DNA-binding site on a histone H1 molecule. (1992) (8)
Polymorphisms of the insulin gene among Japanese subjects. (2001) (7)
Production of interleukin-1 beta-like factor with synovial cell growth promoting activity from adult T-cell leukemia cells. (1991) (7)
A nationwide study of SLE in Japanese identified subgroups of patients with clear signs patterns and associations between signs and age or sex (2014) (7)
AB0431 Post-marketing surveillance of tofacitinib in japanese patients with rheumatoid arthritis: an interim report of safety data (2017) (7)
FRI0278 The First Early Rheumatoid Arthritis, Certolizumab Pegol, Multicenter, Double-Blind, Randomized, Parallel-Group Study: C-Opera, in Patients Fulfilling the 2010 Acr/Eular Classification Criteria, Demonstrates Inhibition of Joint Damage Progression (2014) (6)
Prevalence of cervical lesions in rheumatoid arthritis: cross-sectional study on 263 patients (2000) (6)
Genome-wide single nucleotide polymorphism analyses on rheumatoid arthritis (2004) (6)
Do urinary mononuclear cells reflect disease activity in lupus nephritis? (2003) (6)
AB0495 Post-marketing surveillance of tofacitinib in japanese patients with rheumatoid arthritis: an interim report of safety data (2018) (5)
Etiology of acute ischaemic cerebrovascular disease associated with rheumatoid arthritis: changes with progression of anti‐inflammatory therapy (2018) (5)
An analysis of polyclonal B cell activation in Sjögren's syndrome. Characterization of B cell lines spontaneously established from the peripheral blood. (1986) (5)
High Frequencies of Identical T‐Cell Clonotypes Accumulating in Different Areas of Synovial Lesions of Rheumatoid Arthritis Patients (1995) (4)
Identification of commonly recognized epitopes on a rare autoantigen: poly(ADP-ribose) polymerase. (1994) (4)
Pathogenic roles of IL-6 and IL-6 blocking therapy on rheumatoid arthritis (2003) (4)
Metabolism of chylomicron remnants in transgenic mice expressing apolipoprotein E in the intestine. (1994) (4)
AB0468 Improved physical function, pain, and health related quality of life with certolizumab pegol in japanese rheumatoid arthritis patients with an inadequate response to methotrexate: Results from the jrapid study (2013) (3)
Time course analysis of alpha+ beta+ T cell clones during normal pregnancy. (1996) (3)
3.09 – Degradation of Glycoproteins (2007) (3)
FRI0176 Golimumab, a human anti-TNF monoclonal antibody, administered subcutaneously every four weeks as monotherapy in patients with active rheumatoid arthritis despite dmard therapy: 52-week results of clinical, radiographic and pharmacokinetic assessments (2013) (3)
[Detection of autoantibodies to extractable nuclear antigens in autoimmune diseases of rheumatic origin using immunoblotting--comparison with counter-electrophoresis]. (1990) (3)
AB0469 Improved physical function, pain, and health related quality of life with certolizumab pegol in japanese rheumatoid arthritis patients without methotrexate co-administration: Results from the hikari study (2013) (3)
Molecular cloning of cDNAs expressing SS-B/La protein. (1989) (3)
Accumulation of identical T cell clones in the right and left lobes of the thyroid gland in patients with Graves' disease: analysis of T cell clonotype in vivo. (2000) (3)
Autoantibodies to CTLA-4 enhance T cell proliferation. (2001) (3)
SAT0173 Baseline Parameters Identified in Early, Methotrexate-Naïve Rheumatoid Arthritis Patients with Better Outcomes with Certolizumab Pegol+Methotrexate Compared to Placebo+Methotrexate: Post-Hoc Analyses of C-OPERA, A Randomized, Controlled, Phase 3 Study (2015) (2)
Paired cloning of the T cell receptor alpha and beta genes from a single T cell without the establishment of a T cell clone. (2001) (2)
THU0464 A genome-wide association study of gout in people of european ancestry (2017) (2)
Stimulatory effect of lipoprotein (a) on proliferation of human mesangial cells: role of lipoprotein (a) in renal disease. (1998) (2)
Heterogeneity of RNP and Sm autoantigens in relation to the cell sources and the activated state of the cells (2005) (2)
Citrullinated antigens as C1q-binding and monoclonal rheumatoid factor (mRF)-binding peptides in synovial fluids from rheumatoid arthritis patients. (2009) (2)
LBA O-10 First-line panitumumab versus bevacizumab in combination with mFOLFOX6 for RAS wild-type metastatic colorectal cancer: PARADIGM trial results (2022) (2)
FRI0205 Golimumab administered subcutaneously every four weeks in patients with active rheumatoid arthritis despite methotrexate therapy: long-term clinical, radiographic and safety results, including evaluation of remission using the new acr/eular criteria (2013) (2)
[Autoantibodies as diagnostic markers in congenital heart block]. (1994) (2)
FRI0201 Immunogenicity of certolizumab pegol without concomitant methotrexate and clinical response in rheumatoid arthritis patients: post-hoc analysis of the hikari study (2013) (1)
[Experimental study on the effect of pentoxifylline on blood rheology and microcirculation--a study using an endotoxin shock model]. (1983) (1)
A method to construct a gene that encodes a repetitive amino acid sequence by polymerase chain reaction. (1994) (1)
Epstein–Barr virus‐associated mononucleosis caused by weekly low‐dose methotrexate therapy in a rheumatoid arthritis patient (2006) (1)
[HTLV-I associated arthropathy (HAAP)]. (1990) (1)
Comparison of T‐Cell Receptor Jβ Gene Usage in Spleen Cells of Different Mouse Strains (1999) (1)
Erratum: A functional variant in FCRL3, encoding Fc receptor-like 3, is associated with rheumatoid arthritis and several autoimmunities (2005) (1)
[Optimal dose of PGE1 in the rat mesentery against vasoconstrictive effect of norepinephrine]. (1984) (1)
Functional haplotypes in citrullinating enzyme peptidylarginine deiminase 4 are associated with rheumatoid arthritis (2003) (1)
On-line biosensor for detection of glucose, choline and glutamate simultaneously integrated with microseparation system (2003) (1)
Expansion of identical B-cell clones in the bilateral parotid glands and their circulation in the peripheral blood in a patient with Sjögren's syndrome (2000) (1)
FRI0197 Golimumab monotherapy in patients with active rheumatoid arthritis despite dmard therapy: week 104 results of clinical, radiographic and safety assessments including evaluation of remission using the new acr/eular criteria (2013) (1)
Shear stress-mediated differentiation of vascular progenitors (2005) (1)
Diffuse intervertebral disk calcification in a patient with rheumatoid arthritis. (2000) (1)
OP0111 Tocilizumab discontinuation after attaining remission in patients with rheumatoid arthritis who were treated with tocilizumab alone or in combination with methotrexate: results from a prospective, randomised, controlled study (THE SECOND YEAR OF THE SURPRISE STUDY) (2018) (0)
[Molecular cloning, expression and epitope mapping of nuclear antigen]. (1994) (0)
Rheumatoid Joint: Analysis of Single Cell-Derivedc DNAs: l (2008) (0)
[Plasma cell leukemia with amyloid deposition and osteogenetic change at the site of an extramedullary plasmacytoma]. (1997) (0)
[T cell clonotype analyses using SSCP]. (1994) (0)
THU0199 Week 12 Clinical Response to Certolizumab Pegol Predicts Long-Term Outcomes Regardless of Concomitant Medications and Baseline Disease Characteristics in Japanese Patients with Active Rheumatoid Arthritis (2013) (0)
SP0004 Peptidyl arginine deiminase 4 and rheumatoid arthritis: from human genetics to murine models (2017) (0)
OP0190 Smoking is Not Primarily Associated with ACPA, but with the Presence of Multiple Autoantibodies in RA (2013) (0)
[Analysis of T-cell receptor repertoire in lesions of patients with autoimmune diseases]. (1995) (0)
Isolation and electronic property of Pr@C82 isomer. (1999) (0)
[Characterization of B cell lines spontaneously established from the peripheral blood of Sjögren's syndrome]. (1986) (0)
THU0157 Clinical Outcomes at Week 104 and Analysis of Associated Baseline Factors after An Initial 1 Year of Certolizumab Pegol and MTX Treatment in MTX-Naïve Patients with Early RA: Results from The Second Year of The C-Opera Study (2016) (0)
[Atlas of clinico-pathological study of diseases of the nervous system. 3. Case of cryptococcus meningitis]. (1971) (0)
A Novel Experimental Apparatus (PDL) and Its Application in Higher Education in Japan and Cambodia (2010) (0)
Cyclic strain induces ES cell differentiation into vascular smooth muscle cells via PDGF receptor ß activation (2008) (0)
[T-cell antigen receptor repertoire in patients with inflammatory bowel diseases]. (1995) (0)
Caveola ATP synthase mediates ATP release in vascular endothelial cells exposed to shear stress (2007) (0)
THU0305 A Nationwide Study of Systemic Lupus Erythematosus in Japanese Identified Subgroups of Patients with Clear Signs/Clinical Marker Patterns and Found that Particular Signs/Clinical Markers are Associated with Age and/or Sex (2013) (0)
Citrullinated antigens as C 1 q-binding and monoclonal rheumatoid factor ( mRF )-binding peptides in synovial fluids from rheumatoid arthritis patients (2006) (0)
[Analysis of B cell clonotypes found in tissues from patients with chronic rheumatoid arthritis]. (1997) (0)
388P Early tumor shrinkage (ETS) and depth of response (DpR) analyses in metastatic colorectal cancer (mCRC) treated with first-line mFOLFOX6 plus panitumumab (PAN) or bevacizumab (BEV): Results from the phase III PARADIGM trial (2022) (0)
Cells by Endogenous TCR Expression in the Thymus and from Nonautoreactive T Simultaneously with Their Negative Selection Cells from Autoreactive T Cells Regulatory T + CD25+ Generation of CD4 (2002) (0)
[Levels of tissue-type plasminogen activator and plasminogen activator inhibitor 1 in disseminated intravascular coagulation syndrome]. (1991) (0)
Molecules in Systemic Autoimmune Diseases Autoantibodies to T Cell Costimulatory (1999) (0)
[Enzymatic activity of the serum in the family of a progressive muscular dystrophy patient]. (1969) (0)
[Electrocardiographic findings in the Duchenne-type of progressive muscular dystrophy]. (1968) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Kazuhiko Yamamoto?

Kazuhiko Yamamoto is affiliated with the following schools:

Kazuhiko Yamamoto's Academic­Influence.com Rankings

Why Is Kazuhiko Yamamoto Influential?

Kazuhiko Yamamoto's Published Works

Published Works

What Schools Are Affiliated With Kazuhiko Yamamoto?

Kazuhiko Yamamoto's AcademicInfluence.com Rankings